Vasoactive intestinal polypeptide mRNA and peptide levels are decreased in the anterior pituitary of the human growth hormone-releasing hormone transgenic mouse

Journal of Neuroendocrinology

Volumn 8, Issue 1, 1996, Pages 9-15

  Hyde, James F ^a   Morrison, David G ^a   Drake, Karen W ^a   Moore Jr , Joseph P ^a   Maley, Bruce E ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Growth hormone; Growth hormone releasing hormone; Vasoactive intestinal peptide

Indexed keywords

ESTRADIOL; GALANIN; GROWTH HORMONE RELEASING FACTOR; MESSENGER RNA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADENOHYPOPHYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL TYPE; CONTROLLED STUDY; FRONTAL CORTEX; GENE EXPRESSION; GENE EXPRESSION REGULATION; HORMONE BLOOD LEVEL; HYPOPHYSIS CELL; HYPOPHYSIS TUMOR; HYPOTHALAMUS; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; TISSUE SPECIFICITY; TRANSGENIC MOUSE;

ANIMALS; CEREBRAL CORTEX; ESTRADIOL; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; MALE; MICE; MICE, TRANSGENIC; PITUITARY GLAND, ANTERIOR; PROLACTIN; RNA, MESSENGER; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0030071860     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2826.1996.tb00681.x     Document Type: Article

References (38)

1. Arnaout MA, Garthwaite TL, Martinson DR, Hagen TC. (1986) Vasoactive intestinal polypeptide is synthesized in anterior pituitary tissue. Endocrinology. 119: 2052-2067.
2. Lam KSL, Lechan RM, Minimitani N, Segerson TP, Reichlin S. (1989). Vasoactive intestinal peptide in the anterior pituitary is increased in hypothyroidism. Endocrinology. 124: 1077-1084.
3. Kato Y, Iwasaki Y, Iwasaki J, Abe H, Yanaihara N, Imura H. (1978). Prolactin release by vasoactive intestinal polypeptide in rats. Endocrinology. 103: 554-558.
4. Enjalbert A, Arancibia S, Ruberg M, Priam M, Bluet-Pajot MT, Rotsztejn WH, Kordon C. (1980). Stimulation of in vitro prolactin release by vasoactive intestinal peptide. Neuroendocrinology. 31: 200-204.
5. Hagen TC, Arnaout MA, Scherzer WJ, Martinson DR, Garthwaite TL. (1986). Antisera to vasoactive intestinal polypeptide inhibits basal prolactin release from dispersed anterior pituitary cells. Neuroendocrinology. 43: 641-645.
6. Nagy G, Mulchahey JS, Neill JD. (1988). Autocrine control of prolactin secretion by vasoactive intestinal peptide. Endocrinology. 122: 364-366.
7. Steel JH, Gon G, O'Halloran DJ, Jones PM, Yanaihara N, Ishikawa H, Bloom SR, and Polak JM. (1989). Galanin and vasoactive intestinal polypeptide are colocalized with classic pituitary hormones and show plasticity of expression. Histochemistry. 93: 183-189.
8. Morel G, Beson J, Rosselin G, Dubois PM. (1982). Ultrastructural evidence for endogenous vasoactive intestinal peptide-like immunoreactivity in the pituitary gland Neuroendocrinology. 34: 85-89.
9. Carrillo AJ, Phelps CJ. (1992). Quantification of vasoactive intestinal peptide immunoreactivity in the anterior pituitary glands of intact male and female, ovariectomized, and estradiol benzoate-treated rats. Endocrinology. 131: 964-969.
10. Maurer RA, Gorski J. (1977). Effects of estradiol-17β and pimozide on prolactin synthesis in male and female rats. Endocrinology. 101: 76-84.
11. Maletti M, Rostene WH, Carr L, Scherrer H, Rosten D, Kordon C, Rosselin G. (1982). Interaction between estradiol and prolactin on vasoactive intestinal peptide concentrations in the hypothalamus and in the anterior pituitary of the female rat. Neurosci Lett. 32: 307-313.
12. Lam KSL, Srivastava G, Lechan RM, Lee T, Reichlin S. (1990). Estrogen regulates the gene expression of vasoactive intestinal peptide in the anterior pituitary. Neuroendocrinology. 52: 417-421.
13. O'Halloran DJ, Jones PH, Ghatei MA, Domin J, Bloom SR. (1990). The regulation of neuropeptide expression in rat anterior pituitary following chronic manipulation of estrogen status: a comparison between substance P, neuropeptide Y, neurotensin, and vasoactive intestinal peptide. Endocrinology. 127: 1463-1469.
14. Carrillo AJ, Doherty PC, Guan X, Sturtevant JR, Walro DG. (1991). Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat. Endocrinology. 128: 131-138.
15. Vrontakis ME, Peden LM, Duckworth ML, Friesen HG. (1987). Isolation and characterization of a complementary DNA (galanin) clone from estrogen-induced pituitary tumor messenger RNA. J Biol Chem. 262: 16755-16758.
16. Kaplan LM, Gabriel SM, Koenig JI, Sunday ME, Spindel ER, Martin JB, Chin WW. (1988). Galanin is an estrogen-inducible, secretory product of the rat anterior pituitary. Proc Natl Acad Sci USA. 85: 7408-7412.
17. Phelps C, Hymer WC. (1983). Characterization of estrogen-induced adenohypophseal tumors in the Fischer 344 rat. Neuroendocrinology. 37 :23-31.
18. Hyde JF, Keller BK (1991). Galanin secretion from anterior pituitary cells in vitro is regulated by dopamine, somatostatin and thyrotropin-releasing hormone. Endocrinology. 128: 917-922.
19. Hyde JF, Keller BK, Howard G. (1992). Dopaminergic regulation of galanin gene expression in the rat anterior pituitary gland. J Neuroendocrinol. 4: 449-454.
20. Hyde JF, Howard G. (1992). Regulation of galanin gene expression in the rat anterior pituitary gland by the somatostatin analog SMS 201-995. Endocrinology. 131: 2097-2102.
21. Hammer RE, Brinster RL, Rosenfeld MG, Evans RM, Mayo KE. (1985). Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. Nature. 315: 413-416.
22. Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM. (1988) Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Mol Endocrinol. 2: 606-612.
23. Moore Jr. JP, Morrison DG, Hyde JF. (1994). Galanin gene expression is increased in the anterior pituitary gland of the human growth hormone-releasing hormone transgenic mouse. Endocrinology. 134: 2005-2010.
24. Billestrup N, Swanson LW, Vale W. (1986). Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc Natl Acad Aci USA. 83: 6854-6857.
25. Stefaneanu L, Kovacs K, Horvath E, Asa SL, Losinski NE, Billestrup N, Price J, Vale W (1989). Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological. immunocytochemical and electron microscopic investigation. Endocrinology. 125: 2710-2718.
26. Moore Jr. JP, Hyde JF. (1994). Increased galanin-immunoreactive cell numbers in the anterior pituitary of hGHRH transgenic mice. Soc Neurosci Abstr. 20: 95.
27. Gressens P, Hill JM, Gozes I, Fridkin M, Brenneman DE. (1993). Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature. 362. 155-158.
28. Gozes I, Brenneman DE. (1993). Neuropeptides as growth and differentiation factors in general and VIP in particular. J Mol Neurosci. 4: 1-9.
29. Pysor-Jones RA, Silverlight JJ, Kennedy SJ, Jenkins JS. (1988). Vasoactive intestinal peptide and the stimulation of lactotroph growth by oestradiol in rats. J Endocrinol. 116: 259-265.
30. Mohney RP, Siegel RE, Zigmond RE. (1994). Galanin and vasoactive intestinal peptide messenger RNAs increase following axotomy of adult sympathetic neurons. J Neurobiol. 25: 108-118.
31. Besson J, Rotsztejn W, Laburthe M, Epelbaum J, Beaudet A, Kordon C, Rosselin G. (1979). Vasoactive intestinal peptide (VIP): brain distribution, subcellular localization and effect of deafferentation of the hypothalamus in the male rat. Brain Res. 165: 79-85
32. Samson WK, Said SI, McCann SM. (1979). Radioimmunologic localization of vasoactive intestinal polypeptide in hypothalamic and extrahypothalamic sites in the rat brain. Neurosci Lett. 12: 265-269.
33. Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 72: 248-254.
34. Lamperti ED, Rosen KM, Villa-Komaroff L. (1991). Characterization of the gene and messages for vasoactive intestinal polypeptide (VIP) in rat and mouse. Mol Brain Res. 9: 217-231.
35. Nakamura T, Onno M, Mariage-Samson R, Hillova J, Hill M. (1990). Nucleotide sequence of mouse L19 ribosomal protein cDNA isolated in screening with tre oncogene probes. DNA Cell Biol. 9: 697-703.
36. Chomcyznski P, Sacchi N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162: 156-159.
37. Park O-K., Mayo KE. (1991). Transient expression of progesterone receptor messenger RNA in ovarian granulosa cells after the preovulatory luteinizing hormone surge. Mol Endocrinol. 5: 967-978.
38. Zar JH. (1974) Biostatistical Analysis, 151-162. Prentice-Hall, Englewood Cliffs, NJ.